Helicobacter Pylori and Serum Magnesium in Maintenance of Hemodialysis Patients

Document Type : Letter to Editor

Authors

1 Professor, Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

2 General Practitioner, Medical Plants Research Center, Shahrekord University of Medical Sciences, Shahrekord, Iran

3 Professor, Department of Nephrology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Dear Editor-in-Chief,Gastric complications are common in hemodialysis patients, and Helicobacter pylori (H. pylori) infection is found to have an important role in gastrointestinal diseases in these patients. On the other hand, magnesium is mainly excreted by kidney and magnesium metabolism is perturbed in chronic kidney disease. However, no significant correlation of serum anti-H. pylori specific antibody titer with serum magnesium level has been observed. The elevated serum magnesium in hemodialysis and its higher concentration in the gastric mucosa may promote the gastric colonization of H. pylori in hemodialysis patients, but not in patients with various stages of kidney insufficiency. More studies are needed to prove the association of serum magnesium level and the infection of H. pylori in hemodialysis and finding the clinical relevance of these results

Keywords

References

  1. Jalalzadeh M, Ghadiani MH, Mousavinasab N. Association between helicobacter pylori infection and body mass index, before and after eradication of infection in hemodialysis batients. Journal of Nephropathology 2012; 1(3): 170-6.
  2. Tamadon MR. Comment on: Significant association of serum H. pylori IgG antibody titer with kidney function in renal transplanted patients. Ren Inj Prev 2013; 2(1): 7-8.
  3. Okuno S. Magnesium disorder and its clinical significance in chronic kidney disease. Clin Calcium 2012; 22(8): 1243-9. [In Japanese].
  4. Baradaran A. Comment on: Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients. J Ren Inj Prev 2012; 1(1): 11-2.
  5. Rafieian-Kopaie M, Nasri H. Platelet counts and mean platelet volume in association with serum magnesium in maintenance hemodialysis patients. J Ren Inj Prev 2012; 1(1): 17-21.
  6. Nasri H. Helicobacter pylori infection and its relationship to plasma magnesium in hemodialysis patients. Bratisl Lek Listy 2007; 108(12): 506-9.
  7. Baradaran A, Nasri H. Helicobacter pylori specific IgG antibody and serum magnesium in type-2 diabetes mellitus chronic kidney disease patients. Saudi J Kidney Dis Transpl 2011; 22(2): 282-5.
  8. Amiri M, Kelishadi R. Can salt hypothesis explain the trends of mortality from stroke and stomach cancer in Western europe? Int J Prev Med 2012; 3(6): 377-8.
  9. Amiri M. Stomach cancer mortality in the future: where are we going? Int J Prev Med 2011; 2(2): 101-2.
  10. Rasaf MR, Ramezani R, Mehrazma M, Rasaf MR, Asadi-Lari M. Inequalities in cancer distribution in tehran; a disaggregated estimation of 2007 incidencea by 22 districts. Int J Prev Med 2012; 3(7): 483-92.
  11. Nasri H, Rafieian-Kopaei M. Significant association of serum H. pylori IgG antibody titer with kidney function in renal transplanted patients. JRen Inj Prev 2012; 2(1): 15-21.
  12. Tamadon MR, Saberi Far M, Soleimani A, Ghorbani R, Semnani V, Malek F, et al. Evaluation of noninvasive tests for diagnosis of Helicobacter pylori infection in hemodialysis patients. Journal of Nephropathology 2013; 2(4): 249-53.
Journal of Isfahan Medical School
Volume 31, Issue 239 - Serial Number 239
May and June 2013
Pages 808-810

Files

History

  • Receive Date: 05 June 2013
  • Revise Date: 30 April 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics